InVivo Anti-Mouse CD152/CTLA4 Antibody (9D9)

-YV0029

Catalog: YV0029
Size
Price
Status
Qty.
100mg
$7,800.00
1 week

0

50mg
$5,600.00
1 week

0

25mg
$3,600.00
1 week

0

5mg
$1,100.00
1 week

0

1mg
$300.00
1 week

0

Add to cart

Collected

Collect

Customized Service
Main Information
Target

CD152

Host Species

Mouse

Reactivity

Mouse

Applications

In vivo

Detailed Information
Formulation
0.01M PBS, pH 7.4.
Purification
Protein A/G purified from cell culture supernatant.
Purity
Endotoxin level <1 EU/mg. Purity>95% as determined by SDS-PAGE.
Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Concentration
Lot depended
Clonality
Monoclonal
Isotype
IgG2b, kappa
Related Products
Primary Antibodies
InVivo Rabbit IgG Isotype Control Antibody (HyHEL-10)
YV0009

More→

Primary Antibodies
InVivo Mouse IgG2b Isotype Control Antibody (KLH)
YV0010

More→

Primary Antibodies
InVivo Mouse IgG2b Isotype Control Antibody (IS6-11E5.11)
YV0011

More→

Primary Antibodies
InVivo Mouse IgG2b Isotype Control Antibody (GC198)
YV0012

More→

Primary Antibodies
InVivo Mouse IgG1 Isotype Control Antibody (IS5-21F5)
YV0013

More→

Primary Antibodies
InVivo Mouse IgG1, kappa Isotype Control Antibody (X40)
YV0014

More→

Primary Antibodies
InVivo Mouse IgG1 Isotype Control Antibody (DD7)
YV0015

More→

Primary Antibodies
InVivo Mouse IgG1 Isotype Control Antibody (Ci4)
YV0016

More→

Antigen&Target Information
Gene Name:
CTLA4 CD152
show all
Protein Name:
Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152)
show all
Other Name:
Cytotoxic T-lymphocyte protein 4 ;
Cytotoxic T-lymphocyte-associated antigen 4 ;
CTLA-4 ;
CD antigen CD152 ;
show all
Database Link:
Organism Gene ID SwissProt
Human 1493; P16410;
Background:
This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain , a transmembrane domain , and a cytoplasmic tail. Alternate transcriptional splice variants , encoding different isoforms , have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond , while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus , Graves disease , Hashimoto thyroiditis , celiac disease , systemic lupus erythematosus , thyroid-associated orbitopathy , and other autoimmune diseases. [provided by RefSeq , Jul 2008] ,
show all
Function:
Disease:Genetic variation in CTLA4 influences susceptibility to systemic lupus erythematosus (SLE) [MIM:152700]. SLE is a chronic , inflammatory and often febrile multisystemic disorder of connective tissue. It affects principally the skin , joints , kidneys and serosal membranes. SLE is thought to represent a failure of the regulatory mechanisms of the autoimmune system. ,Disease:Genetic variation in CTLA4 is the cause of susceptibility to celiac disease type 3 (CELIAC3) [MIM:609755]. Celiac disease [MIM:212750] is a multifactorial disorder of the small intestine that is influenced by both environmental and genetic factors. It is characterized by malabsorption resulting from inflammatory injury to the mucosa of the small intestine after the ingestion of wheat gluten or related rye and barley proteins. In its classic form , celiac disease is characterized in children by malabsorption and failure to thrive. ,Disease:Genetic variation in CTLA4 is the cause of susceptibility to insulin-dependent diabetes mellitus type 12 (IDDM12) [MIM:601388]. ,Disease:Genetic variation in CTLA4 may be a cause of susceptibility to Graves disease (GRD) [MIM:275000]. GRD is an autoimmune disorder causing overactivity of the thyroid gland and hyperthyroidism. ,Disease:Genetic variations in CTLA4 are associated with susceptibility to hepatitis B virus infection (HBV infection) [MIM:610424]. Approximately one third of all cases of cirrhosis and half of all cases of hepatocellular carcinoma can be attributed to chronic HBV infection. HBV infection may result in subclinical or asymptomatic infection , acute self-limited hepatitis , or fulminant hepatitis requiring liver transplantation. ,Function:Possibly involved in T-cell activation. Binds to B7-1 (CD80) and B7-2 (CD86) . ,online information:CLTA-4 entry ,similarity:Contains 1 Ig-like V-type (immunoglobulin-like) domain. ,tissue specificity:Widely expressed with highest levels in lymphoid tissues. ,
show all
Cellular Localization:
Cell membrane ; Single-pass type I membrane protein . Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalization.
show all
Research Areas:
For research use only.
show all
Catalog: YV0029
Size
Price
Status
Qty.
100mg
$7,800.00
1 week

0

50mg
$5,600.00
1 week

0

25mg
$3,600.00
1 week

0

5mg
$1,100.00
1 week

0

1mg
$300.00
1 week

0

Add to cart

Collected

Collect

Customized Service

Toggle night Mode

{{pinfoXq.title || ''}}

Catalog: {{pinfoXq.catalog || ''}}
Filter:

All

{{item.name}}

{{pinfo.title}}
-{{pinfo.catalog}}

Filter:

{{item.descr}}

Main Information
Target
{{pinfo.target}}
Reactivity
{{pinfo.react}}
Applications
{{pinfo.applicat}}
Conjugate/Modification
{{pinfo.coupling}}/{{pinfo.modific}}
MW (kDa)
{{pinfo.mwcalc}}
Host Species
{{pinfo.hostspec}}
Isotype
{{pinfo.isotype}}
Learn more
Product {{index}}/{{pcount}}
Prev
Next

{{pvTitle}}

Scroll wheel zooms the picture
{{pvDescr}}